European Union regulators are poised to give the OK to Johnson & Johnson‘s (NYSE:JNJ) $21.3 billion acquisition of Swiss orthopedic giant Synthes, according to Reuters.
PositiveID Corp.
Diabetes: PositiveID makes stride toward artificial pancreas | MassDevice.com On Call
MASSDEVICE ON CALL — PositiveID (OTC:PSID) put the finishing touches on a first-in-class fully synthetic glucose sensing system, a critical component of its ongoing efforts toward developing an artificial pancreas for people with diabetes.
The company’s prototype, developed in partnership with Receptors LLC, can now sense and respond to glucose in human plasma, where it had previously only been demonstrated in a model blood plasma matrix.
Ortho market growth stable but low | Wall Street Beat
The market for hip and knee implants is stable but mired in a low-growth stage, according to analysts who attended the American Academy of Orthopedic Surgeons conference in San Francisco last week.
Although the abrupt departure of Stryker CEO Steve MacMillan drew the lion’s share of attention at the AAOS event, analysts from Barclays Capital and Leerink Swann agreed that the sector’s outlook calls for low-single-digit growth.
Orthopedists spend billions on unneeded tests in self-defense | MassDevice.com On Call
MASSDEVICE ON CALL — Orthopedic surgeons may be spending billions each year ordering unnecessary tests in order to protect themselves from potential liability lawsuits, a national survey found
More than ¾ of survey respondents said they would order fewer tests "if there was significant medical liability reform."
Researchers calculated that the "defensive medicine" efforts cost Medicare about $2.1 billion each year, MedPageToday reported.
FDA clears Philips combination PET/MR scanner | Regulatory Roundup
Philips Ingenuity Scanner
Philips Healthcare (NYSE:PHG) landed 510(k) clearance from the FDA to market its Ingenuity whole-body PET/MR imaging system in the U.S.
The scanner performs both PET and magnetic resonance imaging scans, allowing doctors to acquire images at a significantly lower radiation dose than traditional PET/computer tomography scanners, which use x-rays to make images.
Diabetes: FDA clears t:slim portable pump and iglucose management system | Regulatory Roundup
Tandem Diabetes Care and PositiveID (OTC:PSID) landed FDA clearance for their t:slim portable insulin pump and iglucose diabetes management systems, respectively.
Weekly Wireless Roundup: Positive ID unveils stand-alone wireless diabetes tool
Positive ID unveils stand-alone wireless diabetes tool: PositiveID Corp. (NSDQ:PSID) finished developing a stand-alone device for relaying portable glucose meter readings to an online database. The unit is designed not to require a computer so that users can simply log their readings and shoot them up straight to the server for doctor’s review.